Related Experiment Video

Updated: Aug 30, 2026

Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis
04:01

Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis

Published on: September 8, 2022

Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus

Gianpiero Manes1, Pier Giorgio Rabitti, Antonella Menchise

  • 1Department of Gastroenterology, Cardarelli Hospital, Napoli, Italy.

Pancreas
|October 25, 2003
PubMed
Abstract

Insights

Meropenem and imipenem show similar efficacy in preventing septic complications for severe acute pancreatitis patients. This study found no significant difference in infection rates or clinical outcomes between the two prophylactic antibiotics.

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Critical Care Medicine

Background:

  • Prophylactic antibiotics are crucial for reducing septic complications in acute pancreatitis.
  • Imipenem is the established standard for prophylactic treatment in severe cases.

Purpose of the Study:

  • To compare the efficacy of meropenem against imipenem for preventing septic complications in severe acute pancreatitis.
  • To evaluate meropenem's effectiveness as a prophylactic agent in this patient population.

Main Methods:

  • A prospective randomized study involving 176 patients with necrotizing pancreatitis.
  • Patients received either meropenem (0.5 g t.i.d. IV) or imipenem (0.5 g q.i.d. IV) prophylactically.
  • Outcomes assessed included pancreatic and extrapancreatic infections, complications, surgery rates, mortality, and hospitalization length.

Main Results:

  • Incidence of pancreatic infection was 11.4% for meropenem vs. 13.6% for imipenem.
  • Extrapancreatic infection rates were 21.6% for meropenem vs. 23.9% for imipenem.
  • No significant differences were observed in clinical outcomes or complications between the groups.

Conclusions:

  • Meropenem demonstrates comparable efficacy to imipenem in preventing septic complications in severe acute pancreatitis.
  • Both antibiotics are effective prophylactic agents, with similar safety and clinical outcomes.
  • Meropenem offers a viable alternative to imipenem for prophylactic antibiotic use in this condition.

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: